MicroPort CardioFlow Medtech (HKG:2160) expects to report a decrease in its H1 loss, according to a Hong Kong bourse filing Thursday.
Shares of the medical device firm fell over 1% in recent Friday trade.
The company expects to report a loss of 10 million yuan for the six months ended June 30, a decrease of at least 83% when compared to last year.
MicroPort CardioFlow's financial results are due later this month.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.